Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project
Open Access
- 22 January 2019
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 37 (10) , 2147-2153
Abstract
To define the role of focal laser ablation (FLA) as clinical treatment of prostate cancer (PCa) using the Delphi consensus method.Keywords
This publication has 28 references indexed in Scilit:
- The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic ReviewEuropean Urology, 2014
- Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial DesignEuropean Urology, 2014
- MR Imaging–guided Focal Laser Ablation for Prostate Cancer: Phase I TrialRadiology, 2013
- Long-Term Functional Outcomes after Treatment for Localized Prostate CancerNew England Journal of Medicine, 2013
- MRI-Guided Interventions for the Treatment of Prostate CancerAmerican Journal of Roentgenology, 2012
- Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyThe Lancet Oncology, 2012
- Focal Therapy for Prostate Cancer: Possibilities and LimitationsEuropean Urology, 2010
- Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging AccuracyEuropean Urology, 2010
- Focal Therapy in Prostate Cancer—Report from a Consensus PanelJournal of Endourology, 2010
- Image Guided Photothermal Focal Therapy for Localized Prostate Cancer: Phase I TrialJournal of Urology, 2009